
Diazepam
Diazepam is a long-acting benzodiazepine used for anxiety, alcohol withdrawal, muscle spasm and seizures. Trials support it for short-term anxiety relief and, as an injection or rectal gel, for stopping prolonged seizures; in a Cochrane review, benzodiazepines as a group lowered alcohol-withdrawal seizures compared with placebo (3 studies, 324 people), though the reviewers said no definite conclusions were possible. It did not help acute low back pain when added to naproxen. Alcohol is the critical drink interaction, kava and cannabis are high-severity concerns, and valerian is a moderate one.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Adults (and children 6 months and older for some uses) with an anxiety disorder, acute alcohol withdrawal, muscle spasm or seizures, treated under a prescriber's supervision
Common dosing range
Set by your prescriber. For adults under 65 the Valium label lists 2 to 10 mg two to four times daily for anxiety and seizure disorders, 2 to 10 mg three to four times daily for muscle spasm, and 10 mg three to four times in the first 24 hours of alcohol withdrawal; older adults start at 2 to 2.5 mg once or twice daily
When to expect effects
Blood levels peak in about 1 to 1.5 hours; in an 8-week anxiety trial, diazepam gave the most improvement of any group in the first 2 weeks
Watch out for
Boxed warnings: profound sedation, slowed breathing, coma and death with opioids; abuse, misuse and addiction; and physical dependence, with withdrawal reactions that can be life-threatening if it is stopped suddenly or reduced quickly. Avoid alcohol. Its long half-life means sedation can build up, especially in older adults and people with liver disease.
What is it
Diazepam is a prescription benzodiazepine and a Schedule IV controlled substance. It is sold as generic tablets and as Valium tablets; other forms include Valtoco nasal spray and Libervant buccal film, which are approved for seizure clusters. The Valium label approves the tablets for anxiety disorders and short-term relief of anxiety symptoms, for tremor, agitation and delirium tremens during acute alcohol withdrawal, as an add-on for skeletal muscle spasm (including spasticity and stiff-person syndrome), and as an add-on treatment for seizure disorders. Like all benzodiazepines it carries a boxed warning about use with opioids, about abuse, misuse and addiction, and about dependence and withdrawal reactions. Because it is a sedative that stays in the body for days, alcohol, cannabis, kava and valerian are the main drink and supplement concerns.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
prolonged seizures (status epilepticus), injected or rectal forms Good Evidence | Moderate; about 21 more seizures stopped per 100 treated than with placebo in the paramedic trial | People having a prolonged seizure, treated by paramedics or hospital staff | Minutes; measured on arrival at the emergency department |
generalized anxiety disorder (short-term) Limited Evidence | Moderate in the short term; about 19 more people per 100 reported moderate to marked improvement than with placebo among completers | Adults with generalized anxiety disorder who need short-term relief | Most improvement in the first 2 weeks |
alcohol withdrawal (preventing seizures) Limited Evidence | Large for seizures in a small pooled sample; risk ratio 0.16 versus placebo | Adults going through acute alcohol withdrawal under medical supervision | During the withdrawal period |
acute low back pain (added to naproxen) Limited Evidence | None; identical 11-point improvement in function with diazepam or placebo | Adults with acute non-radicular low back pain seen in an emergency department | Measured at 1 week and 3 months |
prolonged seizures (status epilepticus), injected or rectal forms
- Effect
- Moderate; about 21 more seizures stopped per 100 treated than with placebo in the paramedic trial
- Best fit
- People having a prolonged seizure, treated by paramedics or hospital staff
- Time
- Minutes; measured on arrival at the emergency department
generalized anxiety disorder (short-term)
- Effect
- Moderate in the short term; about 19 more people per 100 reported moderate to marked improvement than with placebo among completers
- Best fit
- Adults with generalized anxiety disorder who need short-term relief
- Time
- Most improvement in the first 2 weeks
alcohol withdrawal (preventing seizures)
- Effect
- Large for seizures in a small pooled sample; risk ratio 0.16 versus placebo
- Best fit
- Adults going through acute alcohol withdrawal under medical supervision
- Time
- During the withdrawal period
acute low back pain (added to naproxen)
- Effect
- None; identical 11-point improvement in function with diazepam or placebo
- Best fit
- Adults with acute non-radicular low back pain seen in an emergency department
- Time
- Measured at 1 week and 3 months
Evidence for 4 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
prolonged seizures (status epilepticus), injected or rectal forms
Disease adjunctIn a randomized, double-blind trial of 205 adults with seizures lasting 5 minutes or more, paramedics gave intravenous diazepam 5 mg, lorazepam 2 mg or placebo. Seizures had stopped by hospital arrival in 42.6% on diazepam and 59.1% on lorazepam versus 21.1% on placebo, and breathing or circulation complications were 10.3% and 10.6% versus 22.5%, a difference that was not statistically significant. A 2014 Cochrane review of 18 trials found intravenous diazepam better than placebo at stopping seizures (risk ratio for seizures not stopping 0.73) and diazepam rectal gel better than placebo gel (risk ratio 0.43), but intravenous lorazepam was better than intravenous diazepam. These results apply to emergency forms, not daily tablets.
Bottom line: Injected or rectal diazepam stops prolonged seizures more often than placebo, though lorazepam did better in head-to-head trials.
generalized anxiety disorder (short-term)
Disease adjunctIn an 8-week randomized, double-blind trial of 230 patients with generalized anxiety disorder (no major depression or panic disorder, Hamilton anxiety score of at least 18), mostly treated in family practice, diazepam (mean maximum dose 26 mg a day) gave the most improvement of any group in the first 2 weeks, mainly for physical symptoms. Among completers, 66% on diazepam reported moderate to marked improvement versus 47% on placebo; imipramine (73%) and trazodone (69%) did as well or better from week 3. A 2019 network meta-analysis of 89 trials found benzodiazepines as a group effective for generalized anxiety disorder but poorly tolerated compared with placebo. Long-term use was not tested.
Bottom line: Diazepam relieves anxiety quickly in the short term, but antidepressants matched or beat it by week 3 to 8.
alcohol withdrawal (preventing seizures)
Disease adjunctA 2010 Cochrane review of 64 randomized trials with 4,309 participants found that benzodiazepines, as a group, prevented alcohol-withdrawal seizures compared with placebo (3 studies, 324 participants, risk ratio 0.16, 95% CI 0.04 to 0.69). Other outcomes did not differ significantly from placebo, and comparisons between different benzodiazepines never reached statistical significance. The authors said no definite conclusions were possible because the trials differed widely. The review did not single out diazepam.
Bottom line: Benzodiazepines such as diazepam lower the risk of withdrawal seizures, but trial quality limits firmer conclusions.
acute low back pain (added to naproxen)
No benefit foundIn a randomized, double-blind trial of 114 emergency department patients with acute, non-traumatic low back pain without sciatica, all received naproxen and were randomized to diazepam 5 mg (1 or 2 tablets every 12 hours as needed) or placebo for a week. Function improved by 11 points on the Roland-Morris disability scale in both groups. At 1 week, 32% on diazepam and 22% on placebo still had moderate or severe pain, and at 3 months 12% and 9%. Side effects were reported by 21% on diazepam and 15% on placebo.
Bottom line: Adding diazepam to naproxen did not improve acute low back pain or function in this trial.
How it works
How to take it
What to track
Bottom line: Your prescriber sets the dose and any taper; avoid alcohol and grapefruit juice, and treat sedating herbs and cannabis as extra sedatives.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Boxed warning: using benzodiazepines with opioids may result in profound sedation, respiratory depression, coma and death. The label reserves the combination for people whose other options are inadequate, at the lowest doses for the shortest time.
Boxed warning: abuse, misuse and addiction, which can lead to overdose or death. Abuse and misuse commonly involve other medicines, alcohol or illicit substances, which raises the risk of serious outcomes.
Boxed warning: dependence and withdrawal reactions. Continued use may lead to clinically significant physical dependence, with risk rising with longer use and higher doses. Abrupt stopping or rapid dose reduction may cause acute withdrawal reactions, including seizures, that can be life-threatening, and some people develop protracted withdrawal lasting weeks to more than 12 months.
Central nervous system depression and potentially fatal slowed breathing, alone or with other sedating drugs or alcohol; falls and fractures, with higher risk in older adults and with other sedatives including alcohol.
Suicidal thoughts or behavior (as with all antiepileptic drugs, about twice the risk of placebo in pooled trials), worsening of existing depression, and paradoxical reactions such as aggression, agitation, hallucinations and increased muscle spasticity.
Raised eye pressure in people with glaucoma, and sedation or withdrawal symptoms in newborns after use late in pregnancy.
Who should avoid it
- People with known allergy to diazepam or any ingredient of the tablets, and people with acute narrow-angle glaucoma (contraindicated). People with open-angle glaucoma may use it only if they are receiving appropriate glaucoma treatment.
- People with severe liver impairment (not recommended) and infants under 6 months (not recommended); people with mild or moderate liver impairment need half the usual dose.
- People with impaired breathing from lung disease or another illness, people with a history of substance use disorder, and people with depression need careful assessment and monitoring by the prescriber.
Pregnancy & breastfeeding
Pregnancy: the Valium label says newborns of mothers who used benzodiazepines late in pregnancy have had sedation (breathing problems, sluggishness, low muscle tone) and withdrawal symptoms, and that published observational studies do not support a clear link between benzodiazepines and major birth defects. Animal studies at high doses showed malformations. Newborns exposed during pregnancy or labor should be watched for sedation, breathing problems, low muscle tone, feeding problems and withdrawal. Women with epilepsy should not stop diazepam abruptly because of the risk of severe seizures. Pregnancy registries for psychiatric and antiepileptic medicines collect outcomes. Breastfeeding: diazepam and its active metabolite are present in breast milk, and there are reports of sedation, poor feeding and poor weight gain in infants exposed to benzodiazepines through milk. The label says to weigh the benefits of breastfeeding against the mother's need for the medicine, and to watch a breastfed infant for sedation, poor feeding and poor weight gain.
Interactions
The Valium label says diazepam adds to the effects of alcohol, including potentially fatal slowed breathing, and that alcohol should be avoided during treatment; the Medication Guide warns the combination can cause severe drowsiness, breathing problems, coma and death. Diazepam and its active breakdown product stay in the body for days (half-lives up to 48 and 100 hours), so the risk does not end with the last dose. Ask your prescriber or pharmacist how long to keep avoiding alcohol, and call emergency services for anyone who is hard to wake or breathing slowly.
Boxed warning: benzodiazepines with opioids may cause profound sedation, respiratory depression, coma and death. In a study of US veterans on opioid pain medicines, a current benzodiazepine prescription was linked to 3.86 times the risk of overdose death. The label limits the combination to people whose other options are inadequate, at the lowest doses for the shortest time.
Kavain, a main kava compound, strengthened GABA-A receptors in lab studies, the same calming system diazepam acts on, so the two can add up to excessive sedation. A published case report describes coma in a man who took kava with alprazolam, another benzodiazepine; no case with diazepam itself has been published. Kava has also been linked to liver injury. Avoid combining them unless your prescriber agrees, and do not stop diazepam suddenly to make room for an herb.
The Valium label says to avoid food or drink containing grapefruit juice during treatment, because grapefruit juice contains strong CYP3A4 blockers and higher diazepam exposure may cause increased and prolonged sedation. In 8 healthy adults, a single oral diazepam dose taken with grapefruit juice instead of water gave 3.2 times the overall exposure and a 1.5 times higher peak. The evidence is for diazepam taken by mouth; the Valtoco nasal spray and Libervant buccal film labels do not mention grapefruit. The label gives no timing gap that makes grapefruit safe; ask your pharmacist about other grapefruit products.
Cannabis can cause sedation and poor coordination, and the label for dronabinol, a prescription form of THC, lists benzodiazepines among drugs that add to its effect on driving and alertness. In a lab study of 10 cannabis users, diazepam alone impaired performance tasks but changed the effects of oral THC little. CBD, found in many cannabis products, raised levels of the active metabolite of clobazam (another benzodiazepine) about 3-fold in the Epidiolex label; diazepam is also cleared partly by CYP2C19, but this has not been tested with diazepam. Do not drive after using both, and tell your prescriber about any cannabis or CBD use.
The label says diazepam produces additive central nervous system depression, which can include potentially fatal slowed breathing, when used with other medicines that cause sedation, and that such medicines should be used with caution. Tell every prescriber and your pharmacist that you take diazepam before anything sedating is added, including over-the-counter sleep aids.
Valerenic acid from valerian strengthened GABA-A receptors in lab studies, so valerian may add to diazepam's sedation. Human evidence is limited: a case report described tremor, dizziness and muscle fatigue in a man taking lorazepam with valerian and passionflower, while in 12 healthy volunteers 14 nights of valerian raised alprazolam's peak level only slightly (25 to 31 ng/ml) without changing overall exposure. A 2014 review concluded that animal and human studies did not confirm an interaction and that valerian's interaction potential seems low, and it noted that the lorazepam case also involved passionflower. Because both act on the same calming system, it is still sensible to treat valerian as a possible added sedative and check with your prescriber.
Drugs that block CYP3A4 or CYP2C19 raise diazepam exposure and may cause stronger, longer sedation, so the label says to consider a lower diazepam dose; inducers such as rifampin and carbamazepine may lower diazepam levels and its effect. Any dose change is made by your prescriber.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.
Warnings (3)
+ alcohol
criticalDiazepam (Valium) and alcohol both depress the central nervous system. The Valium label says diazepam produces additive CNS depressant effects with alcohol, which can include potentially fatal slowed breathing, and that alcohol should be avoided during treatment. Diazepam and its active breakdown product stay in the body for days (half-lives up to 48 and 100 hours), so the risk does not end with a single dose.
+ grapefruit
highGrapefruit juice contains strong inhibitors of CYP3A4, one of the two enzymes that clear diazepam, and the Valium label says to avoid food or drink containing grapefruit juice during treatment because higher diazepam exposure may cause increased and prolonged sedation. In a study of 8 healthy adults given a single oral dose of diazepam, taking it with grapefruit juice instead of water raised overall exposure 3.2-fold and peak levels 1.5-fold. The evidence covers diazepam taken by mouth, and the study measured blood levels, not sedation.
+ kava
highKava's kavalactones act on the GABA-A receptor, the same system diazepam enhances, so combining them can add up to excessive sedation. A published case report describes coma in a man who took kava with alprazolam, another benzodiazepine; no case with diazepam itself has been published. Kava also carries a separate, documented liver-safety signal.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I drink alcohol while taking diazepam?⌄
No. The Valium label says to avoid alcohol, and this page rates the pair critical: together they can cause severe drowsiness, slowed breathing, coma and death. Because diazepam lingers for days, ask your prescriber or pharmacist how long to avoid alcohol after a dose.
Can I take kava or valerian with Valium?⌄
Not without your prescriber. Both herbs act on the same GABA-A calming system. Kava with another benzodiazepine has been linked to coma in a case report, and kava can harm the liver. Valerian's evidence is weaker, but it is still best treated as a second sedative.
Is it safe to use cannabis or CBD with diazepam?⌄
It is best avoided unless your prescriber agrees. Cannabis adds sedation and poor coordination, so do not drive after using both. CBD raised levels of another benzodiazepine in the Epidiolex label; the effect on diazepam has not been tested. Tell your prescriber about any use.
Does grapefruit juice interact with diazepam?⌄
Yes. The Valium label says to avoid food or drink containing grapefruit juice, because it blocks the enzyme that clears diazepam and raises its levels, which can deepen and prolong sedation.
Why does diazepam make me drowsy the next day?⌄
Diazepam and its active breakdown product have long half-lives (up to 48 and 100 hours), so levels build up with daily use, especially in older adults and people with liver disease. If drowsiness is a problem, talk to your prescriber rather than changing the dose yourself.
Can I stop taking diazepam on my own?⌄
The boxed warning says abrupt stopping or a rapid dose reduction after continued use can cause withdrawal reactions, including seizures, that can be life-threatening. Your prescriber can plan a gradual taper if a change is needed.
References by claim
generalized anxiety disorder (short-term)
alcohol withdrawal (preventing seizures)
Amato et al., 2010 · PMC (2010) link
prolonged seizures (status epilepticus), injected or rectal forms
acute low back pain (added to naproxen)
Friedman et al., 2017 · PMC (2017) link
Safety
Interaction: Kava (Piper methysticum)
Interaction: Grapefruit and grapefruit juice
Ozdemir et al., 1998 · PubMed (1998) link
Interaction: Cannabis and THC products
Interaction: Valerian (including valerian tea)
Interaction: Opioids (oxycodone, hydrocodone, codeine, tramadol, morphine, fentanyl, methadone, buprenorphine)
Park et al., 2015 · PMC (2015) link
Track Diazepam with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
